XPONANCE, INC. – Bristol-Myers Squibb Company Transaction History
XPONANCE, INC. portfolio value:
$15.60M
portfolio value
XPONANCE, INC. quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +27.98% | 47.99K shares | 2.39M | $71.09 | 219.53K |
| Q2 2022 | share | Increase | +17.27% | 25.26K shares | 2.52M | $77 | 171.54K |
| Q1 2022 | share | Increase | +1.31% | 1.89K shares | 1.68M | $73.03 | 146.28K |
| Q4 2021 | share | Decrease | -15.70% | -26.88K shares | -1.13M | $62.52 | 144.38K |
| Q3 2021 | share | Decrease | -6.32% | -11.56K shares | -2.08M | $59.17 | 171.27K |
| Q2 2021 | share | Decrease | -30.03% | -78.45K shares | -4.27M | $65.79 | 182.83K |
| Q1 2021 | share | Decrease | -0.83% | -2.18K shares | 152K | $62.15 | 261.29K |
| Q4 2020 | share | Increase | +1.23% | 3.20K shares | 651K | $60.6 | 263.47K |